Stock & Company Details
Aptevo Therapeutics Inc $APVO
Price:
N/A
N/A
1.8M
$2.4M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.01
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
APVO technical indicators
Latest Aptevo Therapeutics Inc (APVO) indicator readings as of 2026-10-29.
APVO's 14-day RSI is 27.4, in oversold territory. At $1.36 it is trading 69.1% below its 200-day moving average of $4.41, and below its 50-day average of $1.88. Price sits near the lower Bollinger Band ($1.31 to $1.98). ADX reads 29.3, indicating a trending market.
Overview
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The Company's lead clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed based on the Company's versatile and robust ADAPTIR™ modular protein technology platform. The ADAPTIR™ platform is capable of generating highly differentiated bispecific antibodies with unique mechanisms of action for the treatment of different types of cancer.
Finance Bot
Ask your questions
Start by typing a question below.
